Clinical Trials Logo

Clinical Trial Summary

The investigators are investigating the effects of combined exposures to diesel exhaust and allergens on lung function and on the immune system. After exposing individuals to either filtered air or carefully controlled levels of diesel exhaust in our exposure chamber, The investigators will use a procedure called bronchoscopy (whereby a thin, flexible tube is passed down the throat and into the lungs) to place a small amount of allergen directly in the lung. 48h later, the bronchoscopy will be repeated so that samples can be collected from the lungs. After 1mo, the entire procedure will be repeated with the alternate exposure.


Clinical Trial Description

1. Purpose/Objective:

To study the effects of diesel exhaust particles on lung function and on allergic responses.

2. Hypotheses:

Hypothesis 1: DE exposure augments systemic oxidative stress from allergen challenge in allergen-sensitized individuals.

Hypothesis 2: DE exposure augments allergen-specific immune response in allergen-challenged airways in sensitized individuals. These responses will be greater in asthmatic individuals than in non-asthmatics.

3. Justification:

The use of diesel engines is increasing because they are more fuel-efficient than gasoline engines. However, diesel engines produce different emissions than gasoline engines. Diesel exhaust is emitted from the tailpipe of both "on-road" diesel engine vehicles (diesel cars, buses and trucks) and "non-road" diesel engines (locomotives, marine vessels and some construction equipment). Diesel exhaust consists of both gaseous and particulate air pollutants. Since people with asthma and allergic diseases appear to be sensitive to air pollution, we would like to know how diesel exhaust (DE) can affects your respiratory and immune systems. We are expecting that any responses that may occur will only be detectable through careful examination of cells and tissues (e.g., bronchoalveolar lavage (fluid from your lungs), blood, urine). Understanding these potentially subtle changes will help us prevent health problems associated with air pollution in the future.

4. Research Method:

This is a blinded crossover experiment between two conditions (DE or filtered air, FA), randomized and counter-balanced to order. Data collection for each condition will be separated by a 4-week washout period.

Following each exposure, The investigators will use bronchoscopy (performed at the Vancouver General Hospital Endoscopy Suite) to deliver a diluent-controlled segmental allergen challenge (SAC). 24 h post-SAC, airway reactivity will be assessed with a methacholine challenge. 48 h post-SAC, bronchoalveolar lavage (BAL), airway brushes and tissue biopsies will be obtained in the same regions for analysis of immune activation. Nasal lavage samples will also be collected to examine responses in the upper airways and blood and urine will be studied to examine systemic responses. Spirometry and methacholine challenge will be used to assess effects on airway function ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01792232
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase N/A
Start date October 2011
Completion date November 2013

See also
  Status Clinical Trial Phase
Completed NCT01612936 - T Cell Effector and Regulatory Mechanisms in Asthma Phase 1
Completed NCT00779116 - Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) Phase 4
Recruiting NCT06002685 - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention N/A
Completed NCT04644783 - Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES) N/A
Recruiting NCT05635266 - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed NCT01454505 - Safety and Efficacy of AL-53817 Nasal Spray Solution Phase 1
Completed NCT00800332 - Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy Phase 2
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Recruiting NCT05119868 - Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring N/A
Completed NCT00801502 - Salmon in Pregnancy Study N/A
Completed NCT00453583 - Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine N/A
Unknown status NCT00892684 - Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease? N/A
Completed NCT00700726 - Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma N/A
Recruiting NCT00350376 - Impact of Asthma Treatments on Daily Activities N/A
Completed NCT00881634 - To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions Phase 1
Completed NCT00881127 - To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions Phase 1
Completed NCT03106493 - Upstate New York Infant Development Screening Program
Completed NCT02017431 - Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction N/A
Completed NCT01711593 - Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma Phase 1
Completed NCT01529437 - Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies Phase 1